Skip to main content
Top

International Journal of Clinical Oncology

Issue 1/2024

Content (9 Articles)

Cancer Biomarker Special Article

Clinical practice guidelines for molecular tumor markers, 2nd edition review part 1

Yoshinori Kikuchi, Hideaki Shimada, Yutaka Hatanaka, Ichiro Kinoshita, Daiki Ikarashi, Tetsuya Nakatsura, Shigehisa Kitano, Yoichi Naito, Toshimichi Tanaka, Keishi Yamashita, Yoko Oshima, Tatsuki Nanami

Radiotherapy Original Article

Multicenter prospective phase II trial of concurrent chemoradiotherapy with weekly low-dose carboplatin for cisplatin-ineligible patients with advanced head and neck squamous cell carcinoma

Yushi Ueki, Shusuke Ohshima, Yusuke Yokoyama, Takeshi Takahashi, Ryusuke Shodo, Keisuke Yamazaki, Kohei Ohtaki, Kohei Saijo, Ryoko Tanaka, Takafumi Togashi, Yuichiro Sato, Satoshi Takano, Jo Omata, Nao Takahashi, Ryuichi Okabe, Arata Horii

Open Access Trastuzumab Deruxtecan Original Article

Trastuzumab deruxtecan in patients with locally advanced or metastatic HER2-positive gastric cancer: a multicenter, open-label, expanded-access study

Kohei Shitara, Kensei Yamaguchi, Kei Muro, Hisateru Yasui, Daisuke Sakai, Takashi Oshima, Masahiro Fujimura, Yuta Sato, Shunsuke Yamazaki, Tatsuya Wakabayashi, Masahiro Sugihara, Takahiro Kamio, Hirokazu Shoji

Open Access Diarrhea Original Article

Clinical impact of diarrhea during enteral feeding after esophagectomy

Ryoma Haneda, Yoshihiro Hiramatsu, Sanshiro Kawata, Wataru Soneda, Eisuke Booka, Tomohiro Murakami, Tomohiro Matsumoto, Yoshifumi Morita, Hirotoshi Kikuchi, Hiroya Takeuchi

Metastasis Original Article

Patient vulnerability is associated with poor prognosis following upfront hepatectomy for colorectal liver metastasis

Kosuke Mima, Hiromitsu Hayashi, Yuki Adachi, Takuya Tajiri, Takashi Ofuchi, Kosuke Kanemitsu, Daisuke Ogawa, Shinsei Yumoto, Takashi Matsumoto, Rumi Itoyama, Yuki Kitano, Shigeki Nakagawa, Hirohisa Okabe, Hideo Baba

Urothelial Cancer Original Article

Real-world outcomes of adjuvant immunotherapy candidates with upper tract urothelial carcinoma: results of a multicenter cohort study

Hirokazu Kagawa, Fumihiko Urabe, Yuria Kiuchi, Kota Katsumi, Ryotaro Yamaguchi, Yushi Suhara, Kentaro Yoshihara, Yuma Goto, Ibuki Sadakane, Yuji Yata, Shun Saito, Shiro Kurawaki, Shino Ajisaka, Keiichiro Miyajima, Kazuhiro Takahashi, Kosuke Iwatani, Yu Imai, Keigo Sakanaka, Minoru Nakazono, Takashi Kurauchi, Sotaro Kayano, Hajime Onuma, Koichi Aikawa, Takafumi Yanagisawa, Kojiro Tashiro, Shunsuke Tsuzuki, Akira Furuta, Jun Miki, Takahiro Kimura

Cystectomy Original Article

Comparison of perioperative outcomes and complications between intracorporeal, extracorporeal, and hybrid ileal conduit urinary diversion during robot-assisted radical cystectomy: a comparative propensity score-matched analysis from nationwide multi-institutional study in Japan

Shuichi Morizane, Keita Nakane, Toshiaki Tanaka, Kenji Zennami, Kentaro Muraoka, Shin Ebara, Noriyoshi Miura, Koichi Uemura, Ryuta Sobu, Akio Hoshi, Rikiya Taoka, Mikio Sugimoto, Hisashi Noma, Hiroshi Sunada, Hiroyuki Nishiyama, Tomonori Habuchi, Ichiro Ikeda, Takashi Saika, Kazuhide Makiyama, Ryoichi Shiroki, Naoya Masumori, Takuya Koie, Atsushi Takenaka

Cervical Cancer Original Article

Impact of COVID-19 on gynecological cancer incidence: a large cohort study in Japan

Hiroaki Komatsu, Yuji Ikeda, Kei Kawana, Satoru Nagase, Kiyoshi Yoshino, Wataru Yamagami, Hideki Tokunaga, Kiyoko Kato, Tadashi Kimura, Daisuke Aoki, the Committee on Gynecologic Oncology of the Japan Society of Obstetrics, Gynecology

Open Access Trastuzumab Deruxtecan Correction

Correction to: Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan

Tomohisa Baba, Masahiko Kusumoto, Terufumi Kato, Yasuyuki Kurihara, Shinichi Sasaki, Katsunori Oikado, Yoshinobu Saito, Masahiro Endo, Yutaka Fujiwara, Hirotsugu Kenmotsu, Masafumi Sata, Toshimi Takano, Ken Kato, Koji Hirata, Tomomi Katagiri, Hanako Saito, Kazuyoshi Kuwano

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine